Weight-loss treatment Wegovy has been approved by the UK’s medicines regulator, for reducing the risk of serious heart problems in overweight and obese people.
Wegovy contains the drug semaglutide, which is already prescribed on the NHS to help some people with a body-mass index (BMI) above 26 lose weight.
And it now becomes the first anti-obesity drug to be used to control heart attacks and strokes in people with established heart problems and a similar BMI.
A trial of 17,600 people suggested weekly semaglutide injections for up to five years reduced major cardiovascular events by 20%.
The UN International Organization for Migration (IOM) issued an alert *on Tuesday over the rapidly…
Regional tensions are mounting as the US-Iran war continues and a rising number of Israeli…
Available for over a yearRight now, research is gathering pace in revolutionising our understanding of…
The young people are campaigning for a new role to be established, similar to the…
Eimear, Pearse, Aoísha and Devyn from Ballycastle want to see a change in how women…
Tuesday is a big day in Washington DC, even by White House standards. Long-time Republican…